Riju Ray

977 total citations
24 papers, 750 citations indexed

About

Riju Ray is a scholar working on Molecular Biology, Physiology and Cellular and Molecular Neuroscience. According to data from OpenAlex, Riju Ray has authored 24 papers receiving a total of 750 indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Molecular Biology, 12 papers in Physiology and 8 papers in Cellular and Molecular Neuroscience. Recurrent topics in Riju Ray's work include Nicotinic Acetylcholine Receptors Study (15 papers), Smoking Behavior and Cessation (11 papers) and Neuropeptides and Animal Physiology (5 papers). Riju Ray is often cited by papers focused on Nicotinic Acetylcholine Receptors Study (15 papers), Smoking Behavior and Cessation (11 papers) and Neuropeptides and Animal Physiology (5 papers). Riju Ray collaborates with scholars based in United States, Canada and Belgium. Riju Ray's co-authors include Caryn Lerman, E. Paul Wileyto, Rachel F. Tyndale, James Loughead, Kosha Ruparel, Robert A. Schnoll, Ruben C. Gur, Steven J. Siegel, Daniel F. Heitjan and Andrew B. Newberg and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Biological Psychiatry and Neuropsychopharmacology.

In The Last Decade

Riju Ray

24 papers receiving 732 citations

Peers

Countries citing papers authored by Riju Ray

Since Specialization

Citations

This map shows the geographic impact of Riju Ray's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Riju Ray with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Riju Ray more than expected).

Fields of papers citing papers by Riju Ray

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Riju Ray. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Riju Ray. The network helps show where Riju Ray may publish in the future.

Co-authorship network of co-authors of Riju Ray

This figure shows the co-authorship network connecting the top 25 collaborators of Riju Ray. A scholar is included among the top collaborators of Riju Ray based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Riju Ray. Riju Ray is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism 2015 ·Journal of Nuclear Medicine ·Jacob G. Dubroff, Robert K. Doot, Mary Falcone, Robert A. Schnoll, Riju Ray, Rachel F. Tyndale, Arthur L. Brody, Catherine Hou, Alexander Schmitz, Caryn Lerman	24
2	DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers 2012 ·Pharmacogenetics and Genomics ·Won‐Ho Lee, Riju Ray, Andrew W. Bergen, Gary E. Swan, Paul D. Thomas, Rachel F. Tyndale, Neal L. Benowitz, Caryn Lerman, David V. Conti	8
3	Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: A pilot feasibility study 2012 ·Drug and Alcohol Dependence ·Rebecca L. Ashare, Riju Ray, Caryn Lerman, Andrew A. Strasser	21
4	μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief 2012 ·Psychopharmacology ·Mary Falcone, Allison Gold, E. Paul Wileyto, Riju Ray, Kosha Ruparel, Andrew B. Newberg, Jacob G. Dubroff, Jean Logan, Jon-Kar Zubieta, Julie A. Blendy, Caryn Lerman	6
5	Association of the Nicotine Metabolite Ratio and CHRNA5/CHRNA3 Polymorphisms With Smoking Rate Among Treatment-Seeking Smokers 2011 ·Nicotine & Tobacco Research ·Mary Falcone, Christopher Jepson, Neal L. Benowitz, Andrew W. Bergen, Angela Pinto, E. Paul Wileyto, Don A. Baldwin, Rachel F. Tyndale, Caryn Lerman, Riju Ray	21
6	Effects of the α4β2 Partial Agonist Varenicline on Brain Activity and Working Memory in Abstinent Smokers 2010 ·Biological Psychiatry ·James Loughead, Riju Ray, E. Paul Wileyto, Kosha Ruparel, (unknown), Steven J. Siegel, Ruben C. Gur, Caryn Lerman	103
7	Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers 2010 ·Human Genetics ·Jinxue Wei, Z. Jennie, Thomas J. Payne, Wenyan Cui, Riju Ray, Nandita Mitra, Caryn Lerman, Ming D. Li	12
8	Convergent Evidence that Choline Acetyltransferase Gene Variation is Associated with Prospective Smoking Cessation and Nicotine Dependence 2010 ·Neuropsychopharmacology ·Riju Ray, Nandita Mitra, Don A. Baldwin, Mengye Guo, Freda Patterson, Daniel F. Heitjan, Christopher Jepson, E. Paul Wileyto, Jinxue Wei, Thomas J. Payne, Z. Jennie, Ming D. Li, Caryn Lerman	31
9	Nicotine Dependence Pharmacogenetics: Role of Genetic Variation in Nicotine-Metabolizing Enzymes 2009 ·Journal of Neurogenetics ·Riju Ray, Rachel F. Tyndale, Caryn Lerman	101
10	Dosimetry of 11C-carfentanil, a μ-opioid receptor imaging agent 2009 ·Nuclear Medicine Communications ·Andrew B. Newberg, Riju Ray, Joshua Scheuermann, Nancy Wintering, J.R. Saffer, Alexander Schmitz, R. Freifelder, Joel S. Karp, Caryn Lerman, Chaitanya Divgi	10
11	Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment 2008 ·The Pharmacogenomics Journal ·Daniel F. Heitjan, David A. Asch, Riju Ray, Margaret Rukstalis, Freda Patterson, Caryn Lerman	27
12	Nicotine abstinence-induced cerebral blood flow changes by genotype 2008 ·Neuroscience Letters ·Ze Wang, Riju Ray, Myles S. Faith, Kathy Tang, E. Paul Wileyto, John A. Detre, Caryn Lerman	31
13	Neuroimaging, genetics and the treatment of nicotine addiction 2008 ·Behavioural Brain Research ·Riju Ray, James Loughead, Ze Wang, John A. Detre, Edward Yang, Ruben C. Gur, Caryn Lerman	18
14	Translating basic science to improve pharmacotherapy for nicotine dependence 2007 ·Nicotine & Tobacco Research ·Jennifer M. Phillips, Steven J. Siegel, Alexandra E. Shields, Freda Patterson, Thomas J. Gould, Andrew A. Strasser, Riju Ray, Angela Pinto, Janet Audrain‐McGovern, Margaret Rukstalis, Kenneth A. Perkins, Julie A. Blendy, Caryn Lerman	6
15	Identification of pharmacogenetic markers in smoking cessation therapy 2007 ·American Journal of Medical Genetics Part B Neuropsychiatric Genetics ·Daniel F. Heitjan, Mengye Guo, Riju Ray, E. Paul Wileyto, Leonard H. Epstein, Caryn Lerman	35
16	Pharmacogenetics and Smoking Cessation with Nicotine Replacement Therapy 2007 ·CNS Drugs ·Riju Ray, Robert A. Schnoll, Caryn Lerman	6
17	Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial 2007 ·Nicotine & Tobacco Research ·Riju Ray, Christopher Jepson, E. Paul Wileyto, John P. Dahl, Freda Patterson, Margaret Rukstalis, Angela Pinto, Wade H. Berrettini, Caryn Lerman	34
18	GENETIC STUDY: Analysis of variations in the tryptophan hydroxylase‐2 (TPH2) gene in cocaine dependence 2006 ·Addiction Biology ·John P. Dahl, Joseph F. Cubells, Riju Ray, Andrew E. Weller, Falk W. Lohoff, Thomas N. Ferraro, David W. Oslin, Kyle M. Kampman, Charles A. Dackis, (unknown), Joel Gelernter, Henry R. Kranzler, Charles P. O’Brien, Wade H. Berrettini	12
19	A functional prodynorphin promoter polymorphism and opioid dependence 2005 ·Psychiatric Genetics ·Riju Ray, Glenn A. Doyle, James J. Crowley, Russell J. Buono, David W. Oslin, Ashwin A. Patkar, Paolo Mannelli, Peter A. DeMaria, Charles P. O Brien, Wade H. Berrettini	28
20	Differential expression of G-protein coupled receptor 56 in human esophageal squamous cell carcinoma 2005 ·Cancer Letters ·Neetu Sud, Rinu Sharma, Riju Ray, (unknown), Ranju Ralhan	32

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact